|23.33||-0.6800||-2.83%||Vol 300.23K||1Y Perf 78.12%|
|Oct 2nd, 2023 16:00 DELAYED|
|- -||- -%|
|Target Price||18.33||Analyst Rating||Moderate Sell 3.60|
|Potential %||-21.43||Finscreener Ranking||☆ 34.60|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||☆ 31.17|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★ 45.40|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||☆ 17.97|
|Price Range Ratio 52W %||68.10||Earnings Rating||Neutral|
|Market Cap||1.09B||Earnings Date||25th Oct 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||25th Oct 2023|
|Estimated EPS Next Report||0.19|
|EPS Growth Next 5 Years %||49.20|
|Avg. Weekly Volume||285.32K|
|Avg. Monthly Volume||320.49K|
|Avg. Quarterly Volume||349.34K|
Core Laboratories N.V. (NYSE: CLB) stock closed at 23.33 per share at the end of the most recent trading day (a -2.83% change compared to the prior day closing price) with a volume of 300.23K shares and market capitalization of 1.09B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Oil & Gas industry, Energy sector and employs 3700 people. Core Laboratories N.V. CEO is Lawrence Bruno.
The one-year performance of Core Laboratories N.V. stock is 78.12%, while year-to-date (YTD) performance is 15.1%. CLB stock has a five-year performance of -80.72%. Its 52-week range is between 13.48 and 27.945, which gives CLB stock a 52-week price range ratio of 68.10%
Core Laboratories N.V. currently has a PE ratio of 63.70, a price-to-book (PB) ratio of 5.46, a price-to-sale (PS) ratio of 2.83, a price to cashflow ratio of 52.20, a PEG ratio of 1.29, a ROA of 2.89%, a ROC of 5.34% and a ROE of 9.89%. The company’s profit margin is 3.58%, its EBITDA margin is 11.80%, and its revenue ttm is $362.16 Million , which makes it $7.81 revenue per share.
Of the last four earnings reports from Core Laboratories N.V., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.19 for the next earnings report. Core Laboratories N.V.’s next earnings report date is 25th Oct 2023.
The consensus rating of Wall Street analysts for Core Laboratories N.V. is Moderate Sell (3.6), with a target price of $18.33, which is -21.43% compared to the current price. The earnings rating for Core Laboratories N.V. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Core Laboratories N.V. has a dividend yield of 0.18% with a dividend per share of $0.04 and a payout ratio of 9.00%.
Core Laboratories N.V. has a Sell technical analysis rating based on Technical Indicators (ADX : 8.23, ATR14 : 1.04, CCI20 : -153.86, Chaikin Money Flow : -0.04, MACD : -0.21, Money Flow Index : 43.78, ROC : -6.00, RSI : 42.13, STOCH (14,3) : 18.17, STOCH RSI : 0.10, UO : 46.77, Williams %R : -81.83), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Core Laboratories N.V. in the last 12-months were: Bruno Lawrence (Option Excercise at a value of $0), Carnes Martha (Option Excercise at a value of $0), Christopher S. Hill (Option Excercise at a value of $0), Dhurata Toli (Sold 0 shares of value $0 ), Dijken Eeuwijk Monique Van (Sold 0 shares of value $0 ), Gwendolyn Schreffler (Sold 12 000 shares of value $0 ), Harvey Klingensmith (Option Excercise at a value of $0), Hill Christopher (Option Excercise at a value of $0), Katherine Murray (Option Excercise at a value of $0), Kevin Daniels (Option Excercise at a value of $0), Klingensmith Harvey (Option Excercise at a value of $0), Kwaku Temeng (Option Excercise at a value of $0), Lawrence Bruno (Option Excercise at a value of $0), Mark Damian Tattoli (Option Excercise at a value of $0), Martha Z. Carnes (Option Excercise at a value of $0), Michael Straughen (Option Excercise at a value of $0), Monique van Dijken Eeuwijk (Option Excercise at a value of $0), Murray Katherine (Option Excercise at a value of $0), Straughen Michael (Option Excercise at a value of $0), Temeng Kwaku (Option Excercise at a value of $0)
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.